The effect of work system on the hand exposure of workers in 18F-FDG production centres

被引:0
|
作者
Małgorzata Wrzesień
机构
[1] University of Lodz,Faculty of Physics and Applied Informatics, Department of Nuclear Physics and Radiation Safety
关键词
Radiopharmaceuticals; Work system; Nuclear medicine; Personnel exposure; Radiation protection;
D O I
暂无
中图分类号
学科分类号
摘要
The production of the 18F isotope—the marker of deoxyglucose (18F-FDG)—the radiopharmaceutical most commonly used in the oncological diagnostic technique of positron emission tomography, requires a cyclotron device. At present, there are nine facilities working in Poland that are equipped with cyclotrons used for producing the short-lived isotopes. The aim of the paper is to determine the hand exposure of workers employed in the two 18F-FDG production centres taking in to account the production procedures and work system in those facilities. Measurements, which included all professional workers exposed to ionizing radiation that were employed in two facilities, were performed by using high-sensitivity thermoluminescent detectors during the routine activities of the personnel. The work system used at the production centre has an impact on the level of the recorded doses. Among the production procedures performed by the staff, the highest ionizing radiation doses have been received by the staff during the 18F-FDG quality control. The maximum estimated annual Hp(0.07) for chemists from the quality control department can exceed the annual skin limit dose (500 mSv). The source of lowest doses on the hands are the cyclotron operating procedure and the 18F-FDG production, provided that these procedures can’t be combined with other production procedures.
引用
收藏
页码:541 / 548
页数:7
相关论文
共 50 条
  • [41] The validation of novel quality control methods in the context of 18F-FDG production
    Cheung, Shilin
    Elizarov, Arkadij
    Lebedev, Artem
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [42] Bioburden studies:: Application in a clinical 18F-FDG production setting.
    Watkins, GL
    Tindall-Cox, CS
    Thede-Reynolds, K
    Hichwa, RD
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 379P - 379P
  • [43] Misinterpretation of 18F-FDG Studies in Oncology
    Thrall, James H.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03) : 494 - 494
  • [44] 18F-FDG labelling of human leukocytes
    Forstrom, LA
    Mullan, BP
    Hung, JC
    Lowe, VJ
    Thorson, LM
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (07) : 691 - 694
  • [45] Postoperative 18F-FDG PET in DTC
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) : 19N - 20N
  • [46] Nodular Fasciitis on 18F-FDG PET
    Gotthardt, Martin
    de Geus-Oei, Lioe-Fee
    Arens, Anne
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (06) : 442 - 442
  • [47] 18F-FDG PET of pulmonary embolism
    Wittram, Conrad
    Scott, James A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (01) : 171 - 176
  • [48] Monitoring Vasculitis with 18F-FDG PET
    Bucerius, Jan
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 60 (03): : 219 - 235
  • [49] 18F-FDG uptake at vaccination site
    Sheehy, Niall
    Drubach, Laura
    PEDIATRIC RADIOLOGY, 2008, 38 (02) : 246 - 246
  • [50] 18F-FDG PET in children with lymphomas
    Gisele Depas
    Caroline De Barsy
    Guy Jerusalem
    Claire Hoyoux
    Marie-Françoise Dresse
    Marie-France Fassotte
    Nancy Paquet
    Jacqueline Foidart
    Pierre Rigo
    Roland Hustinx
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 31 - 38